NewsRoom Articles - Page 112 of 154 - PsychedelicNewsWire (PNW)

ThursdayDec 10, 2020 1:45 pm

Billionaire Peter Thiel Invests in Psychedelic Drug Development

The mental health treatments being used around the world sometimes seem to be doing more harm than good to their consumers, with patients often becoming either addicted to their treatments or treatment resistant. Atai Life Sciences cofounder Florian Brand states that only 50% of individuals respond to selective serotonin reuptake inhibitors, which is the most common depression and anxiety treatment. In addition, this approach can take up to three months for an individual to notice any changes in their symptoms, and individuals have a 33% probability of their bodies resisting the treatment. Backed by its founders, Atai Life Sciences believes…

WednesdayDec 09, 2020 2:30 pm

Governor of Oregon Appoints Advisory Board to Begin Psilocybin Mushroom Therapy Regulation

In last month’s election, Oregon became the first U.S. state to legalize psychedelic mushroom use for various therapy purposes. Oregon Gov. Kate Brown is now implementing measures to kick off the program by accepting applications for board members. The board’s role will be to work out the process for regulating psychedelic treatment access. The Oregon Health Authority issued a notice last week that specified the criteria required for those who would like to apply for positions on the board. The board will consist of 14 to 16 members, and representatives of state departments such as the Department of Justice, public…

MondayDec 07, 2020 3:15 pm

Common Techniques Used in Psychedelic-Assisted Therapy

When discussing psychedelic therapy, many choose to focus on the experience the medication produces and neuropharmacology while ignoring therapy. However, we should acknowledge that without therapy, results from clinical trials wouldn’t be as comprehensive. Therapy plays a critical role in psychedelic therapy. Below, we discuss some of the common therapeutic approaches that psychedelic therapists use to help their patients heal. The Hakomi Technique This method was developed in the 1970s by Ron Kurtz. The technique helps patients focus on the experiences of the present, allowing them to understand the inner workings of their bodies. This method allows patients to restructure and…

MondayDec 07, 2020 2:47 pm

Rritual Superfoods Inc. Fields Powerhouse CPG Lineup to Market Functional Mushrooms

Demand for Functional Mushrooms Experiencing CAGR of Over 10 Percent Market Projected to Increase from $23 billion in 2020 to $34 billion by 2024 61% of the Americans Say Healthfulness Significantly Impacts Their Food Purchases Rritual Superfoods Offering Functional Products Based on Chaga, Lion’s Mane and Reishi Mushrooms Company Led by Stellar Consumer Packaged Goods (“CPG”) Executive Cast Functional foods are fast-rising fare for a growing number of Americans. It’s the same on the world stage, where similar forces are in play. As a result, the functional foods market is projected to continue its current 7.9% CAGR until the year…

FridayDec 04, 2020 12:15 pm

Psychedelics, Kids and Culture

Children and drugs should not mix — unless, of course, the drugs are prescribed by a doctor. However, as the medicalization, decriminalization and legalization of various substances increases or expands, many believe it may be time to have that conversation with their children because drugs are only becoming more accessible as time passes. While you may not expose your children to recreational drugs of any kind, not everyone else may be as quick to say no. In fact, children are often surrounded by information about and access to a variety of drugs. Here is some valuable information about psychedelic substances…

ThursdayDec 03, 2020 10:30 am

Could Psychedelics Be the Drugs That Bridge the Peace Gap?

For the first time, Israel treated patients who suffered from post-traumatic stress disorder with MDMA-assisted psychotherapy in February of this year. This was part of the Phase 3 trials of MDMA, which are a part of a research initiative being carried out in collaboration with the Multidisciplinary Association for Psychedelic Studies (“MAPS”), which is based in the United States. This initiative encompasses 15 sites in Israel, Canada and the U.S. and is expected to end in the last quarter of next year. The body anticipates that it will receive full regulatory approval from the FDA. The first trial that was…

WednesdayDec 02, 2020 3:15 pm

Advocates Set in Motion Efforts to Legalize Psychedelics in Washington State

Marijuana reform advocates in Oregon had separate measures on the ballot that called for the legalization of psilocybin mushrooms for therapeutic use and the decriminalization of the possession of all drugs on election day. Both ballot measures were approved, which may have inspired advocates in nearby Washington State to set their sights on similar reforms. Two measures were recently announced in the state: one aimed at legalizing mushrooms to be used in therapy as well as decriminalizing drug possession on a small scale in 2022, and the second pursues the expansion of the administrative measures already in place into psilocybin…

WednesdayDec 02, 2020 10:00 am

Pure Extracts Technologies Corp. (CSE: PULL) Issues Corporate Update Detailing Operations, Product Strategy and Market Conditions

Pure Extracts is a plant-based extraction company located in British Columbia, Canada that focuses on cannabis, hemp, functional mushrooms Pure Extracts’ “Pure Pulls” and “Pure Mushrooms’” branded products expected to be available by end of Q1 2021 Global cannabis extract market size expected to reach USD$28.5 billion by 2027 with CAGR of 16.6%; global functional mushrooms market expected to reach USD$34.3 billion by 2024 with CAGR of 8% Pure Extracts Technologies (CSE: PULL), a plant-based extraction company focused on cannabis, hemp and functional mushrooms, recently released a corporate update for shareholders and interested investors that provides current information on the…

TuesdayDec 01, 2020 3:00 pm

Psychedelics May Be Answer to Chronic Pain Relief

The U.S. election results revealed the increasing acceptance of cannabis, as voters in various states confirmed widespread desire to legalize the substance for recreational use. We also saw the authorization of the therapeutic use and psilocybin study in Oregon as well as its decriminalization in the District of Columbia. A lot of research has been done on the use of psychedelics to treat various mental health disorders. MDMA, which is commonly known as ecstasy and psilocybin, are currently in phase 3 studies for treatment of PTSD and depression. However, little research has been carried out that focuses on the use…

MondayNov 30, 2020 1:20 pm

Emerging Functional Mushroom Market Ripe with Potential for Rritual Superfoods’ New Product Line

Rritual Superfoods, Inc. is positioning itself to supply the emerging demand for high-potential mushrooms dietary elixirs as wellness products that combat stress, enhance immunity against disease and increase mental clarity Market analysts predict the overall functional foods industry will reach revenues of $268 billion by 2027, and that the functional mushroom segment will grow at a CAGR of 8.04 percent by 2024 as part of the trend Rritual was recently certified by the USDA as an organic product, providing third-party validation Rritual’s quality protocols Rritual’s initial product launch includes elixirs containing mushroom and adaptogenic herb blends such as Chaga-Eleuthero, Lion’s…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000